UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000014469
Receipt No. R000016836
Official scientific title of the study Examine the patient's response and symptom improvement using the intervention under the Integrated Approach to Symptom Management Model for the patients who has lymphedema
Date of disclosure of the study information 2014/07/14
Last modified on 2017/03/31 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Examine the patient's response and symptom improvement using the intervention under the Integrated Approach to Symptom Management Model for the patients who has lymphedema
Title of the study (Brief title) Effect of Integrated Approach to Symptom Management for lymphedema associated with cancer therapy (surgery/ radiation)
Region
Japan

Condition
Condition lymphedema associated with cancer therapy
Classification by specialty
Nursing
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To examine the effect of Integrated Approach to Symptom Management (IASM) for the patients who has lymphedema (hand or leg). The guide book ver.9 for nurse's activity will be used.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes limb circumference
Hand20/ SF-36v2 Japanese
Key secondary outcomes self-efficacy scale for cancer patients
Skindex29
self-care ability (scale)

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Behavior,custom Maneuver
Interventions/Control_1 Period: from July 16th 2014 to March 31st 2016
Frequency: 4 times
First Intervention:
1) Interview according to guidebook.
2) Understanding the symptom experience of the patient.
3) Assessment of self-care ability.
4) Share the plan of the intervention.
5) Provide essential knowledge, essential skill, essential nursing support.
6) Patients record their symptom and practice they have done.
Second and Third Intervention:
1) Listen and understand patient's experience.
2) Practice 3)4)5) of First Intervention.
Final Intervention:
1) Summarize whole practice.
2) Share the emotional feeling.
3) Recognize patient's effort and practice they have done.
4) Measure the outcome scales.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1) Out patients who have lymphedema associated with surgery or radiation therapy.
2) At least 1 month has progressed after the radiation therapy or at least 3 months has progressed after the surgery.
3) Age: over 20 years old.
4) Having the ability to communicate in Japanese and to response to the questionnaire without any cognitive disability.
Key exclusion criteria 1) Less than 3 months after the surgery or less than 1 month after the radiation therapy.
2) Patients who has contraindication of lymphedema drainage therapy.
Target sample size 20

Research contact person
Name of lead principal investigator Atsuko Uchinuno
Organization University of Hyogo
Division name College of Nursing
Address 13-71 Kitaouji-cho,Akashi,Hyogo,673-8588 JAPAN
TEL 078-925-9435
Email a_uchinuno@cnas.u-hyogo.ac.jp

Public contact
Name of contact person Masamichi Fukuda
Organization University of Hyogo
Division name College of Nursing
Address 13-71 Kitaouji-cho,Akashi,Hyogo,673-8588 JAPAN
TEL 078-925-9434
Homepage URL
Email masamichi_fukuda@cnas.u-hyogo.ac.jp

Sponsor
Institute University of Hyogo
Institute
Department

Funding Source
Organization Japans Society for the promotion of Science
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 京都府立医科大学附属病院(京都府)、京都大学医学部附属病院(京都)、大津市民病院(滋賀県)、兵庫県立がんセンター(兵庫県)、松江市立病院(島根県)

Other administrative information
Date of disclosure of the study information
2014 Year 07 Month 14 Day

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2014 Year 07 Month 14 Day
Anticipated trial start date
2015 Year 12 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2014 Year 07 Month 03 Day
Last modified on
2017 Year 03 Month 31 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000016836